CD206+ macrophages are relevant non-invasive imaging biomarkers and therapeutic targets in experimental lung fibrosis.

MLA

Pommerolle, Lenny, et al. “CD206+ Macrophages Are Relevant Non-Invasive Imaging Biomarkers and Therapeutic Targets in Experimental Lung Fibrosis.” Thorax, vol. 79, no. 12, Dec. 2024, pp. 1124–12. EBSCOhost, https://doi.org/10.1136/thorax-2023-221168.

APA

Pommerolle, L., Beltramo, G., Biziorek, L., Truchi, M., Maneschy Dias, A. M., Dondaine, L., Tanguy, J., Pernet, N., Goncalves, V., Bouchard, A., Monterrat, M., Savary, G., Pottier, N., Ask, K., Kolb, M. R. J., Mari, B., Garrido, C., Collin, B., Bonniaud, P., & Burgy, O. (2024). CD206+ macrophages are relevant non-invasive imaging biomarkers and therapeutic targets in experimental lung fibrosis. Thorax, 79(12), 1124–12. https://doi.org/10.1136/thorax-2023-221168

Chicago

Pommerolle, Lenny, Guillaume Beltramo, Leo Biziorek, Marin Truchi, Alexandre Magno Maneschy Dias, Lucile Dondaine, Julie Tanguy, et al. 2024. “CD206+ Macrophages Are Relevant Non-Invasive Imaging Biomarkers and Therapeutic Targets in Experimental Lung Fibrosis.” Thorax 79 (12): 1124–12. doi:10.1136/thorax-2023-221168.